Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

870 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy.
Zuidmeer-Jongejan L, Huber H, Swoboda I, Rigby N, Versteeg SA, Jensen BM, Quaak S, Akkerdaas JH, Blom L, Asturias J, Bindslev-Jensen C, Bernardi ML, Clausen M, Ferrara R, Hauer M, Heyse J, Kopp S, Kowalski ML, Lewandowska-Polak A, Linhart B, Maderegger B, Maillere B, Mari A, Martinez A, Mills EN, Neubauer A, Nicoletti C, Papadopoulos NG, Portoles A, Ranta-Panula V, Santos-Magadan S, Schnoor HJ, Sigurdardottir ST, Stahl-Skov P, Stavroulakis G, Stegfellner G, Vázquez-Cortés S, Witten M, Stolz F, Poulsen LK, Fernandez-Rivas M, Valenta R, van Ree R. Zuidmeer-Jongejan L, et al. Among authors: neubauer a. Int Arch Allergy Immunol. 2015;166(1):41-51. doi: 10.1159/000371657. Epub 2015 Feb 28. Int Arch Allergy Immunol. 2015. PMID: 25765512 Free article. Clinical Trial.
FAST: towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies.
Zuidmeer-Jongejan L, Fernandez-Rivas M, Poulsen LK, Neubauer A, Asturias J, Blom L, Boye J, Bindslev-Jensen C, Clausen M, Ferrara R, Garosi P, Huber H, Jensen BM, Koppelman S, Kowalski ML, Lewandowska-Polak A, Linhart B, Maillere B, Mari A, Martinez A, Mills CE, Nicoletti C, Opstelten DJ, Papadopoulos NG, Portoles A, Rigby N, Scala E, Schnoor HJ, Sigurdardottir ST, Stavroulakis G, Stolz F, Swoboda I, Valenta R, van den Hout R, Versteeg SA, Witten M, van Ree R. Zuidmeer-Jongejan L, et al. Among authors: neubauer a. Clin Transl Allergy. 2012 Mar 9;2(1):5. doi: 10.1186/2045-7022-2-5. Clin Transl Allergy. 2012. PMID: 22409908 Free PMC article.
Recombinant allergens: what does the future hold?
Valenta R, Niespodziana K, Focke-Tejkl M, Marth K, Huber H, Neubauer A, Niederberger V. Valenta R, et al. Among authors: neubauer a. J Allergy Clin Immunol. 2011 Apr;127(4):860-4. doi: 10.1016/j.jaci.2011.02.016. J Allergy Clin Immunol. 2011. PMID: 21458656 Review.
Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy.
Focke-Tejkl M, Weber M, Niespodziana K, Neubauer A, Huber H, Henning R, Stegfellner G, Maderegger B, Hauer M, Stolz F, Niederberger V, Marth K, Eckl-Dorna J, Weiss R, Thalhamer J, Blatt K, Valent P, Valenta R. Focke-Tejkl M, et al. Among authors: neubauer a. J Allergy Clin Immunol. 2015 May;135(5):1207-7.e1-11. doi: 10.1016/j.jaci.2014.09.012. Epub 2014 Nov 13. J Allergy Clin Immunol. 2015. PMID: 25441634 Free PMC article.
Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope-based grass pollen allergy vaccine with allergen extract-based vaccines.
Weber M, Niespodziana K, Linhart B, Neubauer A, Huber H, Henning R, Valenta R, Focke-Tejkl M. Weber M, et al. Among authors: neubauer a. J Allergy Clin Immunol. 2017 Nov;140(5):1433-1436.e6. doi: 10.1016/j.jaci.2017.03.048. Epub 2017 May 31. J Allergy Clin Immunol. 2017. PMID: 28576673 Free PMC article. No abstract available.
Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32.
Niederberger V, Neubauer A, Gevaert P, Zidarn M, Worm M, Aberer W, Malling HJ, Pfaar O, Klimek L, Pfützner W, Ring J, Darsow U, Novak N, Gerth van Wijk R, Eckl-Dorna J, Focke-Tejkl M, Weber M, Müller HH, Klinger J, Stolz F, Breit N, Henning R, Valenta R. Niederberger V, et al. Among authors: neubauer a. J Allergy Clin Immunol. 2018 Aug;142(2):497-509.e9. doi: 10.1016/j.jaci.2017.09.052. Epub 2018 Jan 17. J Allergy Clin Immunol. 2018. PMID: 29361332 Free PMC article. Clinical Trial.
Hypoallergenic derivatives of the major birch pollen allergen Bet v 1 obtained by rational sequence reassembly.
Campana R, Vrtala S, Maderegger B, Jertschin P, Stegfellner G, Swoboda I, Focke-Tejkl M, Blatt K, Gieras A, Zafred D, Neubauer A, Valent P, Keller W, Spitzauer S, Valenta R. Campana R, et al. Among authors: neubauer a. J Allergy Clin Immunol. 2010 Nov;126(5):1024-31, 1031.e1-8. doi: 10.1016/j.jaci.2010.05.023. Epub 2010 Jul 16. J Allergy Clin Immunol. 2010. PMID: 20638112
Altered IgE epitope presentation: A model for hypoallergenic activity revealed for Bet v 1 trimer.
Campana R, Vrtala S, Maderegger B, Dall'Antonia Y, Zafred D, Blatt K, Herrmann H, Focke-Tejkl M, Swoboda I, Scheiblhofer S, Gieras A, Neubauer A, Keller W, Valent P, Thalhamer J, Spitzauer S, Valenta R. Campana R, et al. Among authors: neubauer a. Mol Immunol. 2011 Jan;48(4):431-41. doi: 10.1016/j.molimm.2010.09.016. Epub 2010 Nov 18. Mol Immunol. 2011. PMID: 21093057 Free PMC article.
870 results